Quality of reporting in oncology phase II trials: A 5-year assessment through systematic review

BACKGROUND: Phase II clinical trials are a cornerstone of the development in experimental treatments They work as a "filter" for phase III trials confirmation. Surprisingly the attrition ratio in Phase III trials in oncology is significantly higher than in any other medical specialty. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Langrand-Escure, Julien, Rivoirard, Romain, Oriol, Mathieu, Tinquaut, Fabien, Rancoule, Chloé, Chauvin, Frank, Magné, Nicolas, Bourmaud, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720777/
https://www.ncbi.nlm.nih.gov/pubmed/29216190
http://dx.doi.org/10.1371/journal.pone.0185536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720777/
https://www.ncbi.nlm.nih.gov/pubmed/29216190
http://dx.doi.org/10.1371/journal.pone.0185536

Ejemplares similares